Bone biology and the role of the RANK ligand pathway.

Oncology (Williston Park, N.Y.)

Volumn 23, Issue 14 Suppl 5, 2009, Pages 9-15

  Murthy, Rashmi K ^a   Morrow, P K ^a   Theriault, Richard L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL; ARTICLE; BONE REMODELING; BONE TUMOR; CHEMICALLY INDUCED DISORDER; HUMAN; METABOLIC BONE DISEASE; METASTASIS; MOUSE; MULTIPLE MYELOMA; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE DISEASES, METABOLIC; BONE NEOPLASMS; BONE REMODELING; HUMANS; MICE; MULTIPLE MYELOMA; OSTEOPROTEGERIN; RANK LIGAND;

EID: 77951241241     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)